0001209191-13-037588.txt : 20130723 0001209191-13-037588.hdr.sgml : 20130723 20130723171032 ACCESSION NUMBER: 0001209191-13-037588 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130722 FILED AS OF DATE: 20130723 DATE AS OF CHANGE: 20130723 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Trius Therapeutics Inc CENTRAL INDEX KEY: 0001356857 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 201320630 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6310 NANCY RIDGE DR SUITE 105 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-452-0370 MAIL ADDRESS: STREET 1: 6310 NANCY RIDGE DR SUITE 105 CITY: SAN DIEGO STATE: CA ZIP: 92121 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Finn John CENTRAL INDEX KEY: 0001479788 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34828 FILM NUMBER: 13981907 MAIL ADDRESS: STREET 1: 6310 NANCY RIDGE DRIVE, SUITE 101 CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2013-07-22 0 0001356857 Trius Therapeutics Inc TSRX 0001479788 Finn John C/O TRIUS THERAPEUTICS, INC. 6310 NANCY RIDGE DR, # 105 SAN DIEGO CA 92121 0 1 0 0 Chief Scientific Officer Common Stock 2013-07-22 4 S 0 1000 12.10 D 166860 I By the John and Debbie Finn Trust Common Stock 2151 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 21, 2012 /s/ Michael Morneau, Attorney-in-Fact 2013-07-23